Literature DB >> 28050418

Physician Related Delays in the Diagnosis of Lung Cancer in India.

Krishnappriya Ramachandran1, Balamugesh Thankagunam2, Reka Karuppusami3, D J Christopher4.   

Abstract

INTRODUCTION: Lung cancer is associated with a poor prognosis, if detected late in the disease course. Delay in seeking health care, wrong diagnosis and delay in specialist referral can contribute to delay in diagnosis. AIM: This study was done to assess physician related delays in the diagnosis of lung cancer and the treatments given before presenting to our center.
MATERIALS AND METHODS: A total of 96 consecutive patients diagnosed with lung cancer were enrolled in this study. Details of previous physician consultations, their specialization, diagnoses made and treatments given were obtained from records available with the patients.
RESULTS: Patients, on an average consulted two physicians before presenting to our center. Less than half of the physicians (45%) suspected lung cancer during their evaluation. Around 18% of physicians made an incorrect diagnosis of tuberculosis, out of whom, 88.6% had prescribed anti-tuberculous therapy. Only 27% of physicians referred the patients to higher medical centres for evaluation. Pulmonology Specialists (PS) were the most likely to diagnose lung cancer (p<0.0001). General Medicine Specialists (GMS) were the most likely to misdiagnose cancer as tuberculosis, followed by General Practioners (GP) when compared to PS (p-value =0.0422).
CONCLUSION: Our study demonstrates that, many physicians have a low index of suspicion to diagnose lung malignancy and most commonly misdiagnose it as tuberculosis. It is likely that most patients failed to seek the services of PS directly or through referral either due to a shortage of PS or due to other reasons.

Entities:  

Keywords:  Delay diagnosis; General practitioners; Misdiagnosis; Referral; Specialist; Tuberculosis

Year:  2016        PMID: 28050418      PMCID: PMC5198371          DOI: 10.7860/JCDR/2016/22737.8823

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Clinicopathological study of bronchogenic carcinoma.

Authors:  Rajendra Prasad; Prince James; Vikas Kesarwani; Richa Gupta; Mohan C Pant; Arun Chaturvedi; Anand N Shrivastava
Journal:  Respirology       Date:  2004-11       Impact factor: 6.424

2.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

3.  Delays in the diagnosis and treatment of lung cancer.

Authors:  Eija-Riitta Salomaa; Susanna Sällinen; Heikki Hiekkanen; Kari Liippo
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

4.  Lung cancer: clinical presentation and specialist referral time.

Authors:  G Buccheri; D Ferrigno
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

5.  Clinico-pathological profile of lung cancer in Uttarakhand.

Authors:  Jagdish Rawat; Girish Sindhwani; Dushyant Gaur; Ruchi Dua; Sunil Saini
Journal:  Lung India       Date:  2009-07

6.  Prognosis of patients with lung cancer found in a single chest radiograph screening.

Authors:  E R Salomaa; K Liippo; P Taylor; J Palmgren; J Haapakoski; J Virtamo; O P Heinonen
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

7.  [Delay factors in the diagnosis of lung cancer: a public health problem].

Authors:  J R Pereira; F K Ikari; H Minamoto; J C Cassioli
Journal:  Rev Paul Med       Date:  1991 May-Jun

8.  Delays during the diagnostic evaluation and treatment of lung cancer.

Authors:  Subhash Chandra; Anant Mohan; Randeep Guleria; Vikas Singh; Piush Yadav
Journal:  Asian Pac J Cancer Prev       Date:  2009 Jul-Sep

9.  TNM staging of lung cancer: a quick reference chart.

Authors:  O Lababede; M A Meziane; T W Rice
Journal:  Chest       Date:  1999-01       Impact factor: 9.410

10.  Lung cancer: prevalent trends & emerging concepts.

Authors:  Prabhat Singh Malik; Vinod Raina
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

View more
  4 in total

Review 1.  Artificial intelligence for early diagnosis of lung cancer through incidental nodule detection in low- and middle-income countries-acceleration during the COVID-19 pandemic but here to stay.

Authors:  Susana Goncalves; Pei-Chieh Fong; Mariya Blokhina
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

2.  Consensus study on the health system and patient-related barriers for lung cancer management in South Africa.

Authors:  Witness Mapanga; Shane A Norris; Wenlong C Chen; Charmaine Blanchard; Anita Graham; Laurel Baldwin-Ragaven; Tom Boyles; Bernard Donde; Linda Greef; Ken Huddle; Busisiwe Khumalo; Elizabeth Leepile; Buhle Lubuzo; Raynolda Makhutle; Yusuf Mayet; Merika Tsitsi; Preethi Mistri; Keletso Mmoledi; Mpho Ratshikana-Moloko; Rajen Morer; Lauren Pretorius; Jayshina Punwasi; Guy A Richards; Paul Ruff; Dineo Shabalala; Maureen Sibadela; Nita Soma; Michelle Wong; Maureen Joffe
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

3.  Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer.

Authors:  Anurag Mehta; Anuj Parkash; Meenu Bhatia
Journal:  Asian Pac J Cancer Prev       Date:  2021-08-01

4.  Health systems influence on the pathways of care for lung cancer in low- and middle-income countries: a scoping review.

Authors:  Ugochinyere I Nwagbara; Themba G Ginindza; Khumbulani W Hlongwana
Journal:  Global Health       Date:  2020-03-18       Impact factor: 4.185

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.